Skip to content
Screener

Quest Diagnostics DGX Other income, net (Note 6)

Other income, net (Note 6) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$0-100%
Labcorp Holdings logo
Labcorp HoldingsLH
-$3.5M+89.3%
Opko Health logo
Opko HealthOPK
$1.8M+105%
NeoGenomics logo
NeoGenomicsNEO
-$17K-104%
Exagen Inc. logo
Exagen Inc.XGN
-$132K-184%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20K+143%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.32B+36.1%
Enterprise value$32.08B+26.3%
P/E24.8×+4.4×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating income459438858784
Other income (expense):
Interest expense, net(63)(67)(126)(134)
Other income, net16131410
Total non-operating expense, net(47)(54)(112)(124)
Income before income taxes and equity in earnings of equity method investees412384746660
Income tax expense(88)(97)(162)(156)
Equity in earnings of equity method investees, net of taxes1091427

Cover / Front Matter

FAQ

What is Quest Diagnostics's other income, net (note 6)?
Quest Diagnostics (DGX) reported other income, net (note 6) of $16M in Q2 2026.
How has Quest Diagnostics's other income, net (note 6) changed year-over-year?
Quest Diagnostics's other income, net (note 6) increased by 23.1% year-over-year, from $13M to $16M.
What is the long-term trend for Quest Diagnostics's other income, net (note 6)?
Over 3 years (2021 to 2025), Quest Diagnostics's other income, net (note 6) has grown at a -58.7% compound annual growth rate (CAGR), from $369M to $26M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Quest Diagnostics's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude